
Coding & Documentation
Fam Pract Manag. 2023;30(1):28
Author disclosure: no relevant financial affiliations.
COMPARING TEST DATA FROM PREVIOUS VISIT
MODIFIER JW FOR UNUSED MEDICATION

Report modifier JW on the code for a drug or biologic when administering it from a single-use vial/package results in an amount wasted that exceeds the units reported with the code. Do not report it when administering from a multi-use vial. For example, Drug A is reported with one unit per 10 mg. You administer 20 mg from a 30 mg single-use vial. You report two units of Drug A on one claim line and one unit with modifier JW appended to the drug's code on a second claim line.
It is advisable to check individual payer policies for specific reporting instructions. Not all payers recognize the JW modifier, and some require that you provide additional information such as the product's National Drug Code (NDC) and NDC units (which are often different from HCPCS drug units). Some plans also require that you consider the smallest available drug unit that would provide the required dose of medication with the least waste. For example, Drug A is available in 30 mg or 60 mg single-use vials. You administer 20 mg and report 10 mg as wasted by appending modifier JW even though you provided it from a 60 mg single-use vial.
ADMINISTRATION OF MEDICATION BOUGHT OUTSIDE THE PRACTICE
PROVIDING PRESCRIPTION DRUG SAMPLES DURING E/M VISIT
TESTS CONSIDERED BUT NOT ORDERED
Editor's note (Nov. 15, 2023): The original answer to this question contained outdated information. It has been updated here.
Yes. CPT instructs that a decision to not order a test, after shared decision making, is included in the number tests for the data review category of MDM. Be sure that your documentation supports the consideration of testing and decision not to order the test.